Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingyu Su

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Clinical Nursing|March 7, 2025
Optimising Beyond-Use Date Management and Workload to Reduce Intravenous Medication Errors: A Targeted Intervention StudyQilin Peng, Lingyu Su, Bo Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2023
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluationXiaodong Dou, Qi Sun, Yameng Liu, et al.
European Journal of Medicinal Chemistry|June 10, 2022
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main proteaseXiaodong Dou, Qi Sun, Guofeng Xu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Clinical Nursing|March 7, 2025
Optimising Beyond-Use Date Management and Workload to Reduce Intravenous Medication Errors: A Targeted Intervention StudyQilin Peng, Lingyu Su, Bo Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2023
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluationXiaodong Dou, Qi Sun, Yameng Liu, et al.
European Journal of Medicinal Chemistry|June 10, 2022
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main proteaseXiaodong Dou, Qi Sun, Guofeng Xu, et al.
Pageof 2